Encinitas, CA, United States of America

Samuel Sperry

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Inventor Samuel Sperry

Introduction

Samuel Sperry, an accomplished inventor based in Encinitas, California, has made significant contributions to the field of therapeutics through his innovative work. With a total of five patents to his name, Sperry is recognized for his valuable discoveries that have implications in treating various health conditions, including cancer and inflammation.

Latest Patents

Sperry's latest inventions showcase his focus on Mnk inhibitors, which have therapeutic applications. One of his notable patents involves crystalline forms of Mnk inhibitors, specifically the crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione. This invention provides new crystalline compounds that serve as effective inhibitors of Mnk, presenting opportunities for therapeutic use in treating inflammation and various cancers.

Additionally, he has developed piperidine-substituted Mnk inhibitors, detailing compounds according to specific formulas, which are essential in the creation of pharmaceutically acceptable compositions. These innovations not only contribute to the understanding of Mnk inhibitors but also establish methods for potentially treating serious diseases like cancer through these newly formed compounds.

Career Highlights

Samuel Sperry is currently associated with Effector Therapeutics, Inc., a company that supports his innovative pursuits in the pharmaceutical sector. His expertise in developing Mnk inhibitors underscores his commitment to elevating medical therapies and addressing critical health challenges.

Collaborations

Throughout his career, Sperry has collaborated with esteemed colleagues, including Justin T Ernst and Siegfried Heinz Reich. These collaborations enhance the research and development capabilities within Effector Therapeutics, promoting an environment of innovation and discovery.

Conclusion

In summary, Samuel Sperry is a significant figure in the field of pharmaceuticals, holding multiple patents that advance therapeutic applications. His pioneering work on Mnk inhibitors is a testament to his ingenuity and dedication to improving health outcomes through innovative inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…